Navigation Links
The dark side of fair play
Date:3/7/2014

We often think of playing fair as an altruistic behavior. We're sacrificing our own potential gain to give others what they deserve. What could be more selfless than that? But new research from Northeastern University assistant professor of philosophy Rory Smead suggests another, darker origin behind the kindly act of fairness.

Smead studies spite. It's a conundrum that evolutionary biologists and behavioral philosophers have been mulling over for decades, and it's still relatively unclear why the seemingly pointless behavior sticks around. Technically speaking, spite is characterized as paying a cost to harm another. It yields virtually no positive outcome for the perpetrator. So why would evolutionwhich is supposed to weed out such behaviorslet spite stick around?

Smead's research, conducted in collaboration with Patrick Forber of Tufts University and recently published in the journal Proceedings of the Royal Society B, sheds new light on this nefarious phenomenon.

A common means of studying social behaviors is through simplified models and games. One of these is called the ultimatum game, in which a one player proposes a division of resources the other player can either accept or reject. Suppose each interaction concerns the distribution of 10 one-​​dollar bills. The first player could suggest that he take $5 for himself and give the remaining $5 to the second player. That would be a fair play.

However, that first player could also go for an unfair option in which he keeps $9 for himself and gives just $1 to the second player. While the second player is worse off if he rejects the proposal (he's got ziltch in his pocket instead of $1), he almost always does so in real-​​world versions of the game: It's just not fair.

But when Smead and his colleagues decided to simulate this game mathematically to see how it would play out, they found that in fact the exact opposite happens. Fairne
'/>"/>

Contact: Emily Bhatti
e.bhatti@neu.edu
617-373-3287
Northeastern University
Source:Eurekalert

Page: 1 2 3

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... This release is available in Spanish . ... Exploration of the Sea) met in Bilbao from 5 to 11 ... Dory on the south platform. The meeting was coordinated by AZTI-Tecnalia ... it is held in Bilbao (previously it was held there in ...
... Singapore,s Agency for Science, Technology and Research (A*STAR), have made ... treatment. Their work, published online in the leading journal ... on how to tap on the properties of p53, the ... cells while sparing normal cells. The researchers, led by ...
... timing of umbilical cord clamping at birth should be delayed ... of South Florida,s Center of Excellence for Aging and Brain ... longer period of time allows more umbilical cord blood volume ... period extended, many good physiological "gifts" are transferred through ,nature,s ...
Cached Biology News:Meeting of ICES/CIEM experts in Bilbao on state of demersal fish populations 2Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments 2Do we clamp the umbilical cord too soon? 2Do we clamp the umbilical cord too soon? 3
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Tunnell ... joined the firm as senior statistician and Principal, a ... of experience in the management and analysis of complex ... and chemical industries. , “We’re delighted to have Julia ... in data analytics,” said Dr. Philippe Cini, Group Vice ...
(Date:5/20/2015)... May 20, 2015  Select Medical Corporation ("Select") ... Trade Commission granted early termination of the waiting ... of 1976, as amended, applicable to the acquisition ... a joint venture that Select has created with ... As previously announced, MJ Acquisition Corporation has signed ...
(Date:5/20/2015)... , May 20, 2015  Haemonetics Corporation (NYSE: ... President & CEO, will present at The Jefferies 2015 ... on June 1 st , 2015 at 8:30am ... Mr. Concannon,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... Reportlinker.com announces that a new market research ... Global Biomarkers Industry ... This report analyzes the worldwide markets ... following Technologies and Services: Technologies - Emerging ...
... cells containing a single set of chromosomes for the ... and EMBO. The technique should allow scientists to better ... Mammal cells usually contain two sets of chromosomes ... father. The genetic information contained in these chromosome sets ...
... Sept. 7, 2011 BioStorage Technologies, a global ... cold chain logistics, will host its third in ... Symposia in conjunction with the 4th annual Biorepositories ... presentations from a diverse panel of multidisciplinary professionals ...
Cached Biology Technology:Global Biomarkers Industry 2Global Biomarkers Industry 3Global Biomarkers Industry 4Global Biomarkers Industry 5Global Biomarkers Industry 6Global Biomarkers Industry 7Global Biomarkers Industry 8Global Biomarkers Industry 9Global Biomarkers Industry 10Global Biomarkers Industry 11Global Biomarkers Industry 12Global Biomarkers Industry 13Global Biomarkers Industry 14Global Biomarkers Industry 15Global Biomarkers Industry 16Global Biomarkers Industry 17Global Biomarkers Industry 18Global Biomarkers Industry 19Global Biomarkers Industry 20Global Biomarkers Industry 21Global Biomarkers Industry 22Global Biomarkers Industry 23Global Biomarkers Industry 24Global Biomarkers Industry 25Scientists create mammalian cells with single chromosome set 2BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference 2BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference 3